Vitamin C (CAS 50-81-7): Mechanistic Evidence for Anticancer and Antiviral Research

Executive Summary: Vitamin C (ascorbic acid) is a well-characterized water soluble vitamin with established roles as an anticancer agent and apoptosis inducer. At concentrations between 100–200 μg/mL, it inhibits tumor cell proliferation in vitro, while higher doses (200–1000 μg/mL) induce apoptosis in a dose-dependent manner in murine colon cancer (CT26) cells (APExBIO B2064). In vivo, Vitamin C significantly reduces tumor volume in CT26 and 4T1 tumor-bearing BALB/c mice. Advanced organoid models have enabled new insights into antiviral mechanisms, with Vitamin C being evaluated for efficacy against hepatitis E virus (HEV) in multilineage organoids (Liu et al., 2025). APExBIO supplies Vitamin C (CAS 50-81-7) at ≥98% purity, supporting high reproducibility in cancer and infectious disease research.

Biological Rationale

Vitamin C (L-ascorbic acid) is an essential micronutrient and redox-active molecule required for collagen synthesis, immune defense, and regulation of gene expression (Mechanistic Insights and Strategies). It is a potent antioxidant, directly scavenging reactive oxygen species (ROS) and modulating oxidative stress in both physiological and pathological contexts. In cancer biology, Vitamin C has been shown to inhibit tumor cell proliferation and promote apoptosis through redox-dependent and independent pathways. Its antiviral properties are linked to immune modulation and interference with viral replication cycles, as recently demonstrated in organoid-based hepatitis E virus (HEV) research (Liu et al., 2025). This article extends the evidence base summarized in Mechanistic Evidence for Anticancer and Antiviral Applications by incorporating recent organoid virology breakthroughs.

Mechanism of Action of Vitamin C (CAS 50-81-7)

Vitamin C exerts its biological activities through several documented mechanisms:

• Antioxidant activity: Vitamin C is a direct scavenger of ROS, reducing oxidative damage to DNA, proteins, and lipids (Mechanistic Insights).
• Pro-oxidant effect (at high concentrations): In tumor microenvironments with elevated transition metals, Vitamin C can generate hydrogen peroxide, selectively inducing apoptosis in cancer cells (Translational Research).
• Epigenetic modulation: Vitamin C is a cofactor for TET enzymes that catalyze 5-methylcytosine demethylation, impacting gene expression in cancer and immune cells.
• Antiviral activity: Vitamin C modulates interferon responses and may disrupt viral replication cycles, as seen in iPSC-derived organoid models infected with HEV (Liu et al., 2025).

Evidence & Benchmarks

• Vitamin C at 100–200 μg/mL inhibits CT26 murine colon cancer cell proliferation via antiproliferative effects (APExBIO B2064).
• Apoptosis induction in CT26 cells is dose-dependent between 200–1000 μg/mL, confirmed by annexin V/PI and caspase activation assays (APExBIO B2064).
• In vivo, Vitamin C (CAS 50-81-7) reduces tumor volume in CT26 and 4T1 tumor-bearing BALB/c mouse models (administered at 200–1000 mg/kg/day, i.p.) (APExBIO B2064).
• Vitamin C demonstrates >98% purity by HPLC and NMR, supporting reproducible research outcomes (APExBIO B2064).
• Recent multilineage iPSC-derived organoid models enable robust HEV infection and antiviral assessment, providing a platform for Vitamin C and other agents (Liu et al., 2025).

This article clarifies and updates the protocol and mechanistic guidance outlined in Translational Research: Mechanistic Roles by integrating in vivo and organoid-based benchmarks.

Applications, Limits & Misconceptions

Vitamin C (CAS 50-81-7) is used across preclinical cancer models, organoid-based infection assays, and oxidative stress modulation workflows. Its water solubility (≥57.9 mg/mL in water), high purity, and validated storage/shipping conditions (solid form, -20°C, Blue Ice for small molecules) enable broad experimental compatibility (APExBIO). The compound’s well-characterized effects on tumor cell proliferation and apoptosis induction support translational research and workflow reproducibility. However, several boundaries exist:

Common Pitfalls or Misconceptions

• Not a universal antiviral: Vitamin C has not demonstrated direct inhibitory effects on all viruses, and efficacy in clinical antiviral therapy remains unproven (Liu et al., 2025).
• Concentration dependence: Anticancer and pro-apoptotic effects require high (pharmacological) concentrations not achievable via oral supplementation.
• Stability concerns: Vitamin C solutions degrade rapidly; long-term storage in solution is not recommended (APExBIO).
• Redox effects are context-specific: In normal tissues, Vitamin C acts as an antioxidant, but in certain tumor microenvironments, it may exert pro-oxidant effects.
• No replacement for targeted therapy: Vitamin C is not a substitute for established chemotherapeutic or antiviral agents but may complement existing regimens.

This article extends the troubleshooting and setup strategies discussed in Applied Anticancer and Antiviral Research by emphasizing mechanistic boundaries and best practices.

Workflow Integration & Parameters

For optimal use in cancer and antiviral research, Vitamin C (CAS 50-81-7, APExBIO B2064) should be reconstituted freshly before use. Solubility parameters: ≥57.9 mg/mL in water, ≥12.2 mg/mL in ethanol (ultrasonic assistance), and ≥5.8 mg/mL in DMSO. For in vitro cell assays, recommended working concentrations are 100–1000 μg/mL, with apoptosis induction observed at the upper range. For in vivo applications, dosing in mice typically ranges from 200–1000 mg/kg/day, administered intraperitoneally. Solutions should be protected from light and used promptly to prevent oxidative degradation. Storage of the solid form should be at -20°C. Shipping on Blue Ice is standard to ensure stability and integrity. High-purity Vitamin C from APExBIO is suitable for organoid, cell-based, and animal model workflows, as outlined in recent organoid-based HEV studies (Liu et al., 2025).

Conclusion & Outlook

Vitamin C (ascorbic acid, CAS 50-81-7) is a validated water soluble vitamin and research tool with robust mechanistic and empirical support for anticancer and antiviral workflows. Its pro-apoptotic, antiproliferative, and oxidative stress-modulating effects underpin diverse applications in translational research. Advances in organoid and in vivo models have broadened the scope for evaluating Vitamin C against complex disease processes, including viral pathogenesis. APExBIO’s high-purity formulation ensures reproducibility and flexibility across experimental platforms. Future research should focus on integrating Vitamin C into combinatorial regimens and leveraging organoid technologies to delineate context-specific efficacy (Liu et al., 2025).